The system will be installed at the Victorian Centre for Functional Genomics which is the first lab to have such a platform.
RASTRUM was developed in collaboration with UNSW professors Justin Gooding and Maria Kavallaris, while the printer itself was built by engineers from the private firm Inventia Life Science.
A statement from Inventia said RASTRUM would replace a manual process and increase the possibility of research and drug development in realistic models.
The RASTRUM platform at the Peter MacCallum Cancer Centre in Melbourne.
It is claimed to be able to produce 1000 three-dimensional cell models in less than six hours, something that would consumer than 50 hours were it done manually.
“This is a novel and exciting platform for cancer research,” said Associate Professor Kaylene Simpson, who is head of the VCFG at Peter Mac.
“The ability to create realistic three-dimensional cell models through an automated and scalable process will vastly accelerate our research progress and advance therapeutic target discovery.
“We have a very clear vision for the clinical applications of this technology."
Inventia chief executive Dr Julio Ribeiro said: “Our collaboration with Peter MacCallum Cancer Centre provides a powerful opportunity to drive progress in cancer research.
“This installation will seriously accelerate the creation of three-dimensional tissues allowing researchers high throughput, to drive discovery-based cancer research.
“This is a unique collaboration of Australian science, research and innovation and I wish to thank Peter MacCallum Cancer Centre for sharing our vision.”
Inventia recently won Series A investment support, raising $10 million from Scott Farquhar’s investment firm, Skip Capital, Luca Belgiorno-Nettis through Prisma, Blackbird, AirTree Ventures, and the CSIRO venture arm, Main Sequence Ventures.
Photos: courtesy Inventia Life Science